PTC
RGN

Philadelphia Trust Company’s REGENERX BIOPHARMACEUTICALS RGN Stock Holding History

Philadelphia Trust Company’s Portfolio RGN Stock Details RGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,721
Closed -$707K – 215
2019
Q1 		$707K Sell
1,721
-148,279
-99% -$60.9M 0.06% 137
2018
Q4 		$23K Buy
+150,000
New +$23K ﹤0.01% 176
2017
Q2 		– Sell
-150,000
Closed -$44K – 231
2017
Q1 		$44K Buy
+150,000
New +$44K ﹤0.01% 212

Other funds holding RGN

WJA
Williams Jones & Associates New York $4.82B AUM 19.95% 1-Year Est. Return
DBIA
Dumont & Blake Investment Advisors Princeton, New Jersey $400M AUM 21.87% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return

Philadelphia Trust Company's RGN Position: Q2 2019 in Review

Philadelphia Trust Company sold out of REGENERX BIOPHARMACEUTICALS (RGN) in Q2 2019, closing a stake of 1,721 shares — an estimated $707K sold.

Philadelphia Trust Company first reported a position in RGN in Q1 2017 and held it in 3 quarters. The position peaked at $707K in Q1 2019. 3 funds tracked by Wall St. Rank hold RGN as of Q2 2019.

  • Philadelphia Trust Company reported no remaining REGENERX BIOPHARMACEUTICALS position as of Q2 2019 after selling out during the quarter.
  • Philadelphia Trust Company sold 1,721 REGENERX BIOPHARMACEUTICALS shares in Q2 2019, an estimated $707K.
  • Philadelphia Trust Company first reported a position in REGENERX BIOPHARMACEUTICALS in Q1 2017 and held it in 3 quarters.
  • Philadelphia Trust Company's REGENERX BIOPHARMACEUTICALS position peaked at $707K in Q1 2019.
  • 3 funds tracked by Wall St. Rank held REGENERX BIOPHARMACEUTICALS as of Q2 2019.

Based on Philadelphia Trust Company's 13F filing for Q2 2019, filed 8 Aug 2019.